See the evidence behind your molecule.
Start with Ground Truth — the evidence-grounded foundation for decision intelligence. Fixed scope. Four weeks. Five deliverables.
Research Validation
Built on Peer-Reviewed Science
108 verified sources across 17 research domains. Every platform concept traced to evidence. No claim unsupported.
0Verified sources cited
0Research domains analyzed
0+Peer-reviewed papers
0Unsupported claimsEvery concept has at least emerging evidence
Foundation
Three Anchor Papers
The foundational research that validates the core mechanism — LLMs develop internal representations that can be parameterized, calibrated, and steered to produce behaviorally realistic synthetic outputs.
01
Emotion Concepts and their Function in a Large Language Model
Sofroniew N, Kauvar I, Saunders W, Chen R, Henighan T, et al.
Anthropic ResearchApril 2026
171emotion concepts discovered
Key Finding
Claude Sonnet 4.5 develops internal linear representations of 171 emotion concepts that causally influence behavior. These are functional representations — they track the operative emotion concept at a given token position and steer downstream outputs.
Platform Bridge
If LLMs develop functional internal representations that causally steer behavior, then parameterizing those representations through persona conditioning, evidence grounding, and constraint systems is a validated mechanism for producing reliable synthetic outputs.
02
Generative Agent Simulations of 1,000 People
Park JS, Zou CQ, Shaw A, Hill BM, Cai C, Morris MR, et al.
Stanford HAINovember 2024
85%normalized accuracy
Key Finding
Interview-grounded generative agents replicated real individuals' General Social Survey responses at 85% normalized accuracy — compared to participants' own test-retest reliability two weeks later.
Platform Bridge
Validates the evidence-grounded calibration approach — deeper calibration using contextual information improves synthetic agent fidelity. Behavior Labs' SAM module calibrates synthetic HCPs, payers, and patients using the Knowledge Graph rather than simple persona descriptions.
03
Scaling Synthetic Data Creation with 1,000,000,000 Personas
Chan X, Wang X, Yu D, Mi H, Yu D
Tencent AI LabJune 2024
1Bpersonas validated
Key Finding
Persona Hub — a collection of 1 billion diverse personas — demonstrates that personas act as "distributed carriers of world knowledge" that can tap into almost every perspective within an LLM.
Platform Bridge
Validates that persona parameterization reliably steers diverse LLM outputs at scale. Behavior Labs' synthetic actor taxonomy operates at multiple resolutions across four categories — the scaling principle is the same: each parameterization unlocks different domain knowledge.
Validation Matrix
50 Concepts. Every One Traced to Evidence.
Architecture concepts, operational concepts, model principles, modules, and proof points — each independently assessed against the research literature.
36%
32%
20%
10%
2%
18 Strong
16 Moderate
10 Emerging
5 Benchmark
1 Counter-Evidence
Architecture Concepts
Operational Concepts
Model Principles
Modules
Proof Points
Research Domains
17 Research Domains. One Integrated Platform.
Each domain contributes peer-reviewed evidence to specific platform capabilities. No single paper validates the integration — that is Behavior Labs' original contribution.
Cross-Concept Validation
Five Points of Convergence
Where three or more independent research streams validate the same platform thesis. Convergence is stronger than any single paper.
01
StrongEvidence-Grounded Synthetic Simulation Produces Decision-Grade Intelligence
Converging Research Streams
Domains 01–05LLMs produce behaviorally realistic synthetic respondents
Domain 15MCCS 87.8% accuracy on real HTA decisions
Domain 04Multi-source evidence grounding reduces hallucinations 40%+
Anchor 1Functional internal representations causally steer behavior
Anchor 2Calibration depth determines fidelity (85% accuracy)
Validated Platform Thesis
Evidence-grounded synthetic panels produce intelligence comparable to traditional market research — the mechanism works, the calibration approach improves fidelity, the evidence grounding prevents hallucination, and the outputs achieve decision-grade accuracy.
02
StrongComputational Models Have Regulatory Acceptance for Clinical Development
Converging Research Streams
Domain 1445 FDA approvals accepted external control data
Domain 14PROCOVA EMA-qualified, FDA-concurred
Domain 09FDA Modernization Act 2.0 and 3.0 authorize AI/ML methods
Domain 06157+ QSP submissions to FDA by 2020
Domain 09FDA-EMA jointly adopted 10 principles for AI
Validated Platform Thesis
The TDO module operates in a regulatory environment that explicitly accepts computational models. External control arms, biomarker-driven enrichment, and adaptive designs all have documented precedent.
03
Moderate–StrongKnowledge Compounding Persists Through AI Systems
Converging Research Streams
Domain 12Argote — knowledge in tools persists when members leave
Domain 12Figge — AI as persistent organizational memory
Domain 12MIT Sloan — GenAI creates compounding effect on learning
Domain 02NP-KG — each new source enriches all existing entities
CS-0711 staff turnovers, zero knowledge loss
Validated Platform Thesis
The Knowledge Graph produces compounding intelligence supported by organizational learning theory, AI-specific extensions, knowledge graph methodology, and internal demonstration.
04
StrongMulti-Agent Architectures with Role Specialization Outperform Single Agents
Converging Research Streams
Domain 03Du et al. (ICML) — multi-agent debate reduces hallucinations
Domain 03D3 framework — role specialization produces reliable evaluations
Domain 03180-config study — 3-4 agents optimal
Domain 03Ebrahimi — credibility scoring maintains adversarial resilience
Domain 03Adimulam — policy-enforced auditable multi-agent orchestration
Validated Platform Thesis
The Agent Mesh — a small number of role-specialized agents (progressive, delegating, contrarian) — aligns with empirical findings that small, specialized teams outperform both single agents and large swarms.
05
StrongAI-Driven Pharmacovigilance Outperforms Traditional Methods
Converging Research Streams
Domain 13Warner — ML outperforms disproportionality measures
Domain 13Golder — NLP/ML detects under-reported events from unstructured data
Domain 13Kim — F1=0.948 for ADR detection with LLMs
Domain 13Botsis — operationally deployed PV AI is vanishingly rare
CS-064-month earlier signal detection; $2.8M vs. $47M recall
Validated Platform Thesis
The technology is proven. The deployment gap is documented. The PMS module bridges this gap — demonstrated in CS-06 with quantified patient safety and cost outcomes.
Source Quality
Where the Evidence Comes From
80+ papers from top-tier conferences, Nature family journals, regulatory publications, and leading medical journals.
Top-tier ML Conferences
4
ICML 2024ICLR 2024UIST 2023COLING 2025
Nature Family Journals
6
Nature CommsSci Datanpj Digital MedSci Reports
Medical & Pharma Journals
12
Drug SafetyPharmaceut MedJ Med EconFront Pharmacol
Regulatory Publications
5
EMAFDAEFPIAASME V&V 40
arXiv & medRxiv Preprints
15
Stanford HAITencent AI LabAnthropicMCCS
NBER & HBS Working Papers
3
Horton (Homo Silicus)Brand (WTP)Doshi (Strategic AI)
Industry Publications
5
ISPECSISMIT SloanBio-IT World
To the Researchers
This platform exists because thousands of researchers chose to publish their work, share their data, and advance the science. Every module in our system traces to their findings. Every validation in this document is their achievement, not ours. We built the integration — they built the foundation.
Anthropic/Stanford HAI/Tencent AI Lab/MIT Sloan/Harvard / MGH/European Medicines Agency/Cold Spring Harbor Laboratory/AstraZeneca/Unlearn.AI
We are committed to advancing the science alongside you — and to ensuring this work reaches the patients and decision-makers who need it most.
Emotion Concepts and their Function in a Large Language Model
Sofroniew N, Kauvar I, Saunders W, et al.
Anthropic Research · 2026
Generative Agent Simulations of 1,000 People
Park JS, Zou CQ, Shaw A, et al.
Stanford HAI · 2024
Scaling Synthetic Data Creation with 1,000,000,000 Personas
Chan X, Wang X, Yu D, Mi H, Yu D
Tencent AI Lab · 2024
Out of One, Many: Using Language Models to Simulate Human Samples
Argyle LP, Busby EC, Fulda N, et al.
Political Analysis · 2023
Large Language Models as Simulated Economic Agents
Horton JJ, Filippas A, Manning BS
NBER / ACM EC · 2023
Using Large Language Models to Simulate Multiple Humans
Aher GV, Arriaga RI, Kalai AT
ICML · 2023
Using LLMs for Market Research
Brand J, Israeli A, Ngwe D
Harvard Business School · 2023
Generative Agents: Interactive Simulacra of Human Behavior
Park JS, O'Brien JC, Cai CJ, et al.
UIST '23 · 2023
Improving Factuality and Reasoning through Multiagent Debate
Du Y, Li S, Torralba A, et al.
ICML · 2024
An Adversary-Resistant Multi-Agent LLM System via Credibility Scoring
Ebrahimi S, Dehghankar M, Asudeh A
IJCNLP-AACL · 2025
Building a Knowledge Graph to Enable Precision Medicine
Chandak P, Huang K, Zitnik M
Scientific Data (Nature) · 2023
Biomedical Knowledge Graph Learning for Drug Repurposing
Bang D, Lim S, Lee S, Kim S
Nature Communications · 2023
MEGA-RAG: Multi-Evidence Guided Answer Refinement
—
Frontiers in Public Health · 2025
Can LLMs Express Their Uncertainty? An Empirical Evaluation
Xiong M, et al.
ICLR · 2024
PROCOVA: Prognostic Covariate Adjustment Methodology
Unlearn.AI
EMA Qualified / FDA Concurred · 2021–2025
The Use of External Controls in FDA Regulatory Decision Making
Gao C, et al.
Therapeutic Innovation & Regulatory Science · 2021
Monte Carlo Committee Simulation for Drug Reimbursement
Janoudi G, Rada M, Yasinov E, Richter T
medRxiv · 2026
Artificial Intelligence for Drug Safety Across the Lifecycle
—
Pharmaceuticals (MDPI) · 2025
AI/ML Innovations in Oncology Clinical Trials
Azenkot T, Rivera DR, Stewart MD, Patel SP
ASCO Educational Book · 2025
AI and Innovation in Clinical Trials
—
npj Digital Medicine (Nature) · 2025
Artificial Intelligence: Applications in Pharmacovigilance
Warner J, Prada Jardim A, Albera C
Pharmaceutical Medicine · 2025
Transformer-Based Models for ADR Detection
Kim M, Kim KE, Kwon JH, et al.
Therapeutic Advances in Drug Safety · 2025
SciAgents: Automating Scientific Discovery Through Multi-Agent Reasoning
Ghafarollahi A, Buehler MJ
Advanced Materials · 2025
Turbocharging Organizational Learning With GenAI
—
MIT Sloan Management Review · 2025
AI-Human Learning Systems: The Strategic Role of AI
Figge P, Anderson E, Lewis K
The Learning Organization (SAGE) · 2025
Transformative Roles of Digital Twins in Drug Discovery
Maharjan R, Kim NA, Kim KH, Jeong SH
Int J Pharmaceutics · 2025
Knowledge Graphs and Drug Discovery: An Update
Serra A, Fratello M, Federico A, Greco D
Expert Opinion on Drug Discovery · 2025
Federated Deep Learning Enables Cancer Subtyping by Proteomics
Cai Z, Boys EL, Noor Z, et al.
Cancer Discovery · 2025
Artificial Intelligence for Wargaming and Modeling
Davis PK, Bracken P
J Defense Modeling & Simulation · 2022
LLM Strategic Reasoning: Agentic Study through Behavioral Game Theory
—
arXiv · 2025
Reflection Paper on the Use of AI in the Lifecycle of Medicines
EMA CHMP/CVMP
European Medicines Agency · 2024
The Rise of Small Language Models in Healthcare
—
arXiv · 2025
Emotion Concepts and their Function in a Large Language Model
Sofroniew N, Kauvar I, Saunders W, et al.
Anthropic Research · 2026
Generative Agent Simulations of 1,000 People
Park JS, Zou CQ, Shaw A, et al.
Stanford HAI · 2024
Scaling Synthetic Data Creation with 1,000,000,000 Personas
Chan X, Wang X, Yu D, Mi H, Yu D
Tencent AI Lab · 2024
Out of One, Many: Using Language Models to Simulate Human Samples
Argyle LP, Busby EC, Fulda N, et al.
Political Analysis · 2023
Large Language Models as Simulated Economic Agents
Horton JJ, Filippas A, Manning BS
NBER / ACM EC · 2023
Using Large Language Models to Simulate Multiple Humans
Aher GV, Arriaga RI, Kalai AT
ICML · 2023
Using LLMs for Market Research
Brand J, Israeli A, Ngwe D
Harvard Business School · 2023
Generative Agents: Interactive Simulacra of Human Behavior
Park JS, O'Brien JC, Cai CJ, et al.
UIST '23 · 2023
Improving Factuality and Reasoning through Multiagent Debate
Du Y, Li S, Torralba A, et al.
ICML · 2024
An Adversary-Resistant Multi-Agent LLM System via Credibility Scoring
Ebrahimi S, Dehghankar M, Asudeh A
IJCNLP-AACL · 2025
Building a Knowledge Graph to Enable Precision Medicine
Chandak P, Huang K, Zitnik M
Scientific Data (Nature) · 2023
Biomedical Knowledge Graph Learning for Drug Repurposing
Bang D, Lim S, Lee S, Kim S
Nature Communications · 2023
MEGA-RAG: Multi-Evidence Guided Answer Refinement
—
Frontiers in Public Health · 2025
Can LLMs Express Their Uncertainty? An Empirical Evaluation
Xiong M, et al.
ICLR · 2024
PROCOVA: Prognostic Covariate Adjustment Methodology
Unlearn.AI
EMA Qualified / FDA Concurred · 2021–2025
The Use of External Controls in FDA Regulatory Decision Making
Gao C, et al.
Therapeutic Innovation & Regulatory Science · 2021
Monte Carlo Committee Simulation for Drug Reimbursement
Janoudi G, Rada M, Yasinov E, Richter T
medRxiv · 2026
Artificial Intelligence for Drug Safety Across the Lifecycle
—
Pharmaceuticals (MDPI) · 2025
AI/ML Innovations in Oncology Clinical Trials
Azenkot T, Rivera DR, Stewart MD, Patel SP
ASCO Educational Book · 2025
AI and Innovation in Clinical Trials
—
npj Digital Medicine (Nature) · 2025
Artificial Intelligence: Applications in Pharmacovigilance
Warner J, Prada Jardim A, Albera C
Pharmaceutical Medicine · 2025
Transformer-Based Models for ADR Detection
Kim M, Kim KE, Kwon JH, et al.
Therapeutic Advances in Drug Safety · 2025
SciAgents: Automating Scientific Discovery Through Multi-Agent Reasoning
Ghafarollahi A, Buehler MJ
Advanced Materials · 2025
Turbocharging Organizational Learning With GenAI
—
MIT Sloan Management Review · 2025
AI-Human Learning Systems: The Strategic Role of AI
Figge P, Anderson E, Lewis K
The Learning Organization (SAGE) · 2025
Transformative Roles of Digital Twins in Drug Discovery
Maharjan R, Kim NA, Kim KH, Jeong SH
Int J Pharmaceutics · 2025
Knowledge Graphs and Drug Discovery: An Update
Serra A, Fratello M, Federico A, Greco D
Expert Opinion on Drug Discovery · 2025
Federated Deep Learning Enables Cancer Subtyping by Proteomics
Cai Z, Boys EL, Noor Z, et al.
Cancer Discovery · 2025
Artificial Intelligence for Wargaming and Modeling
Davis PK, Bracken P
J Defense Modeling & Simulation · 2022
LLM Strategic Reasoning: Agentic Study through Behavioral Game Theory
—
arXiv · 2025
Reflection Paper on the Use of AI in the Lifecycle of Medicines
EMA CHMP/CVMP
European Medicines Agency · 2024
The Rise of Small Language Models in Healthcare
—
arXiv · 2025